Supreme Court to decide on Medtronic, Boston Scientific patent fight by June

Medtronic's ($MDT) ongoing patent fight with Boston Scientific ($BSX) over the use of cardiac device tech finally had its day before the U.S. Supreme Court on Nov. 5. Now comes the waiting. Reuters reported that a ruling in the matter is expected by the end of June 2014. At issue: cardiac resynchronization therapy devices Boston Scientific licensed from Mirowski Family Ventures. Medtronic also licensed the patents under an agreement to pay royalties for new products using the technology in question. But it has sued, seeking a determination that it should not have to pay royalties for new products. An appeals process brought the case to the U.S. Supreme Court, where justices focused a lot of their questioning on Mirowski's lawyer, according to the article. The eventual ruling could affect what the Boston Business Journal noted has become an increasingly common practice: the licensing of another company's patented technology. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.